SO Southern | $82.66
+0.2% | 1/23/2025 | Downgraded by | Guggenheim | - | Buy -> Neutral | | Low | View details for Guggenheim rating of Southern (NYSE:SO) on 1/23/2025 |
EIX Edison International | $58.73
+0.8% | 1/23/2025 | Downgraded by | Guggenheim | - | Buy -> Neutral | | Low | View details for Guggenheim rating of Edison International (NYSE:EIX) on 1/23/2025 |
CMS CMS Energy | $66.33
-0.4% | 1/23/2025 | Downgraded by | Guggenheim | - | Buy -> Neutral | | Low | View details for Guggenheim rating of CMS Energy (NYSE:CMS) on 1/23/2025 |
CNP CenterPoint Energy | $32.36
-0.3% | 1/23/2025 | Downgraded by | Guggenheim | - | Buy -> Neutral | | Medium | View details for Guggenheim rating of CenterPoint Energy (NYSE:CNP) on 1/23/2025 |
NWE NorthWestern Energy Group | $53.56
+0.4% | 1/23/2025 | Upgraded by | Guggenheim | - | Neutral -> Buy | | Low | View details for Guggenheim rating of NorthWestern Energy Group (NYSE:NWE) on 1/23/2025 |
IDA IDACORP | $107.75
-3.6% | 1/23/2025 | Upgraded by | Guggenheim | - | Neutral -> Buy | | High | View details for Guggenheim rating of IDACORP (NYSE:IDA) on 1/23/2025 |
EXC Exelon | $39.13
-0.2% | 1/23/2025 | Upgraded by | Guggenheim | - | Neutral -> Buy | | Medium | View details for Guggenheim rating of Exelon (NASDAQ:EXC) on 1/23/2025 |
EVRG Evergy | $62.77
-0.2% | 1/23/2025 | Upgraded by | Guggenheim | - | Neutral -> Buy | | Low | View details for Guggenheim rating of Evergy (NASDAQ:EVRG) on 1/23/2025 |
DTE DTE Energy | $120.16
-0.1% | 1/23/2025 | Upgraded by | Guggenheim | - | Neutral -> Buy | | Low | View details for Guggenheim rating of DTE Energy (NYSE:DTE) on 1/23/2025 |
AEP American Electric Power | $97.74
+0.3% | 1/23/2025 | Upgraded by | Guggenheim | - | Neutral -> Buy | | Low | View details for Guggenheim rating of American Electric Power (NASDAQ:AEP) on 1/23/2025 |
|
NXST Nexstar Media Group | $155.95
+1.5% | 1/22/2025 | Reiterated by | Guggenheim | Analyst Curry Baker | Buy -> Buy | | Low | View details for Guggenheim rating of Nexstar Media Group (NASDAQ:NXST) on 1/22/2025 |
GH Guardant Health | $45.63
-3.3% | 1/22/2025 | Reiterated by | Guggenheim | Analyst Subbu Nambi | Buy -> Buy | | High | View details for Guggenheim rating of Guardant Health (NASDAQ:GH) on 1/22/2025 |
FSLR First Solar | $168.52
-2.0% | 1/22/2025 | Reiterated by | Guggenheim | Analyst Joseph Osha | Buy -> Buy | $335.00 -> $335.00 | High | View details for Guggenheim rating of First Solar (NASDAQ:FSLR) on 1/22/2025 |
DT Dynatrace | $55.14
+3.6% | 1/22/2025 | Reiterated by | Guggenheim | Analyst J. Difucci | Neutral -> Neutral | | Low | View details for Guggenheim rating of Dynatrace (NYSE:DT) on 1/22/2025 |
EXEL Exelixis | $32.84
-0.1% | 1/22/2025 | Reiterated by | Guggenheim | Analyst Michael Schmidt | Buy -> Buy | | High | View details for Guggenheim rating of Exelixis (NASDAQ:EXEL) on 1/22/2025 |
IPSC Century Therapeutics | $0.88
-0.8% | 1/22/2025 | Reiterated by | Guggenheim | Analyst Michael Schmidt | Buy -> Buy | | Low | View details for Guggenheim rating of Century Therapeutics (NASDAQ:IPSC) on 1/22/2025 |
DDOG Datadog | $142.32
+1.6% | 1/22/2025 | Reiterated by | Guggenheim | Analyst Howard Ma | Neutral -> Neutral | | Low | View details for Guggenheim rating of Datadog (NASDAQ:DDOG) on 1/22/2025 |
NOW ServiceNow | $1,121.92
-0.3% | 1/22/2025 | Reiterated by | Guggenheim | Analyst John Difucci | Sell -> Sell | $716.00 | Low | View details for Guggenheim rating of ServiceNow (NYSE:NOW) on 1/22/2025 |
NWSA News | $27.78
-0.1% | 1/22/2025 | Target Raised by | Guggenheim | Analyst Curry Baker | Buy -> Buy | $40.00 -> $43.00 | Low | View details for Guggenheim rating of News (NASDAQ:NWSA) on 1/22/2025 |
TGT Target | $135.92
+0.1% | 1/22/2025 | Target Raised by | Guggenheim | Analyst Robert Drbul | Buy -> Buy | $145.00 -> $155.00 | Low | View details for Guggenheim rating of Target (NYSE:TGT) on 1/22/2025 |
NFLX Netflix | $973.98
+2.1% | 1/22/2025 | Target Raised by | Guggenheim | Analyst Michael Morris | Buy -> Buy | $950.00 -> $1,100.00 | High | View details for Guggenheim rating of Netflix (NASDAQ:NFLX) on 1/22/2025 |
PRGS Progress Software | $55.10
-3.8% | 1/17/2025 | Reiterated by | Guggenheim | Analyst John Difucci | Buy -> Buy | $83.00 -> $83.00 | High | View details for Guggenheim rating of Progress Software (NASDAQ:PRGS) on 1/17/2025 |
BRKR Bruker | $57.42
-4.4% | 1/17/2025 | Reiterated by | Guggenheim | Analyst S. Nambi | Buy -> Buy | | Medium | View details for Guggenheim rating of Bruker (NASDAQ:BRKR) on 1/17/2025 |
KROS Keros Therapeutics | $11.36
-0.3% | 1/17/2025 | Reiterated by | Guggenheim | Analyst V. Divan | Neutral -> Neutral | | Medium | View details for Guggenheim rating of Keros Therapeutics (NASDAQ:KROS) on 1/17/2025 |
NTRA Natera | $170.69
-0.7% | 1/17/2025 | Target Raised by | Guggenheim | Analyst Subbu Nambi | Buy -> Buy | $170.00 -> $200.00 | High | View details for Guggenheim rating of Natera (NASDAQ:NTRA) on 1/17/2025 |
INFY Infosys | $21.76
+0.7% | 1/17/2025 | Reiterated by | Guggenheim | Analyst Jonathan Lee | Neutral -> Neutral | | Low | View details for Guggenheim rating of Infosys (NYSE:INFY) on 1/17/2025 |
LTH Life Time Group | $28.68
+0.8% | 1/17/2025 | Reiterated by | Guggenheim | Analyst John Heinbockel | Buy -> Buy | $29.00 -> $32.00 | High | View details for Guggenheim rating of Life Time Group (NYSE:LTH) on 1/17/2025 |
OTLK Outlook Therapeutics | $2.07
-0.9% | 1/17/2025 | Reiterated by | Guggenheim | Analyst Eddie Hickman | Buy -> Buy | $12.00 -> $12.00 | High | View details for Guggenheim rating of Outlook Therapeutics (NASDAQ:OTLK) on 1/17/2025 |
NFLX Netflix | $973.98
+2.1% | 1/13/2025 | Target Raised by | Guggenheim | Analyst Michael Morris | Buy -> Buy | $825.00 -> $950.00 | Low | View details for Guggenheim rating of Netflix (NASDAQ:NFLX) on 1/13/2025 |
IGMS IGM Biosciences | $1.72
+0.9% | 1/10/2025 | Downgraded by | Guggenheim | Analyst M. Schmidt | Buy -> Neutral | | High | View details for Guggenheim rating of IGM Biosciences (NASDAQ:IGMS) on 1/10/2025 |
SWTX SpringWorks Therapeutics | $34.94
-0.2% | 1/8/2025 | Target Lowered by | Guggenheim | - | Buy -> Buy | $80.00 -> $78.00 | Medium | View details for Guggenheim rating of SpringWorks Therapeutics (NASDAQ:SWTX) on 1/8/2025 |
WMG Warner Music Group | $30.07
+0.2% | 1/8/2025 | Target Lowered by | Guggenheim | - | Buy -> Buy | $44.00 -> $40.00 | Medium | View details for Guggenheim rating of Warner Music Group (NASDAQ:WMG) on 1/8/2025 |
PWR Quanta Services | $357.02
-0.3% | 1/8/2025 | Initiated by | Guggenheim | Analyst J. Osha | Neutral | | High | View details for Guggenheim rating of Quanta Services (NYSE:PWR) on 1/8/2025 |
PRIM Primoris Services | $86.92
-1.2% | 1/8/2025 | Initiated by | Guggenheim | Analyst J. Osha | Buy | $102.00 | Medium | View details for Guggenheim rating of Primoris Services (NASDAQ:PRIM) on 1/8/2025 |
MTZ MasTec | $157.85
-0.8% | 1/8/2025 | Initiated by | Guggenheim | Analyst J. Osha | Buy | $195.00 | Low | View details for Guggenheim rating of MasTec (NYSE:MTZ) on 1/8/2025 |
EXEL Exelixis | $32.84
-0.1% | 1/7/2025 | Target Raised by | Guggenheim | - | Buy -> Buy | $33.00 -> $42.00 | Low | View details for Guggenheim rating of Exelixis (NASDAQ:EXEL) on 1/7/2025 |
WDAY Workday | $252.57
-0.4% | 1/6/2025 | Upgraded by | Guggenheim | Analyst J. Difucci | Sell -> Neutral | | N/A | View details for Guggenheim rating of Workday (NASDAQ:WDAY) on 1/6/2025 |
PANW Palo Alto Networks | $187.02
-0.4% | 1/6/2025 | Downgraded by | Guggenheim | Analyst J. Difucci | Neutral -> Sell | $130.00 -> $130.00 | N/A | View details for Guggenheim rating of Palo Alto Networks (NASDAQ:PANW) on 1/6/2025 |
MDB MongoDB | $258.60
-0.8% | 1/6/2025 | Upgraded by | Guggenheim | Analyst H. Ma | Neutral -> Buy | $300.00 -> $300.00 | N/A | View details for Guggenheim rating of MongoDB (NASDAQ:MDB) on 1/6/2025 |
CRM Salesforce | $331.28
-0.4% | 1/6/2025 | Downgraded by | Guggenheim | Analyst J. Difucci | Neutral -> Sell | $247.00 -> $247.00 | N/A | View details for Guggenheim rating of Salesforce (NYSE:CRM) on 1/6/2025 |
URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad) Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days.
It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year.
This is where fortunes are made – often LITERALLY overnight. >> Register for the Workshop Now |
DT Dynatrace | $55.14
+3.6% | 1/6/2025 | Downgraded by | Guggenheim | Analyst J. Difucci | Buy -> Neutral | | N/A | View details for Guggenheim rating of Dynatrace (NYSE:DT) on 1/6/2025 |
SRZN Surrozen | $11.77
-7.8% | 1/3/2025 | Upgraded by | Guggenheim | Analyst Y. Suneja | Neutral -> Buy | $45.00 -> $45.00 | N/A | View details for Guggenheim rating of Surrozen (NASDAQ:SRZN) on 1/3/2025 |
ACAD ACADIA Pharmaceuticals | $17.79
-0.6% | 1/3/2025 | Downgraded by | Guggenheim | Analyst Y. Suneja | Buy -> Neutral | $23.00 -> $20.00 | N/A | View details for Guggenheim rating of ACADIA Pharmaceuticals (NASDAQ:ACAD) on 1/3/2025 |
RDDT Reddit | $182.52
-0.7% | 12/20/2024 | Initiated by | Guggenheim | Analyst M. Morris | Buy | $210.00 | N/A | View details for Guggenheim rating of Reddit (NYSE:RDDT) on 12/20/2024 |
KR Kroger | $58.60
-0.7% | 12/19/2024 | Initiated by | Guggenheim | - | Buy | $68.00 | N/A | View details for Guggenheim rating of Kroger (NYSE:KR) on 12/19/2024 |
BRKR Bruker | $57.42
-4.4% | 12/19/2024 | Initiated by | Guggenheim | Analyst S. Nambi | Buy | $72.00 | N/A | View details for Guggenheim rating of Bruker (NASDAQ:BRKR) on 12/19/2024 |
CYRX Cryoport | $8.42
-1.8% | 12/19/2024 | Initiated by | Guggenheim | Analyst S. Nambi | Buy | $11.00 | N/A | View details for Guggenheim rating of Cryoport (NASDAQ:CYRX) on 12/19/2024 |
DHR Danaher | $242.16
-0.8% | 12/19/2024 | Initiated by | Guggenheim | Analyst S. Nambi | Buy | $275.00 | N/A | View details for Guggenheim rating of Danaher (NYSE:DHR) on 12/19/2024 |
MRVI Maravai LifeSciences | $5.15
-1.6% | 12/19/2024 | Initiated by | Guggenheim | Analyst S. Nambi | Neutral | | N/A | View details for Guggenheim rating of Maravai LifeSciences (NASDAQ:MRVI) on 12/19/2024 |
NEOG Neogen | $11.65
-0.8% | 12/19/2024 | Initiated by | Guggenheim | Analyst S. Nambi | Buy | $15.00 | N/A | View details for Guggenheim rating of Neogen (NASDAQ:NEOG) on 12/19/2024 |
KROS Keros Therapeutics | $11.36
-0.3% | 12/16/2024 | Downgraded by | Guggenheim | Analyst V. Divan | Buy -> Neutral | | N/A | View details for Guggenheim rating of Keros Therapeutics (NASDAQ:KROS) on 12/16/2024 |
RH RH | $440.38
-3.1% | 12/13/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $425.00 -> $550.00 | N/A | View details for Guggenheim rating of RH (NYSE:RH) on 12/13/2024 |
APGE Apogee Therapeutics | $37.89
-4.0% | 12/12/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | | N/A | View details for Guggenheim rating of Apogee Therapeutics (NASDAQ:APGE) on 12/12/2024 |
ARVN Arvinas | $18.49
+1.5% | 12/12/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | | N/A | View details for Guggenheim rating of Arvinas (NASDAQ:ARVN) on 12/12/2024 |
BWA BorgWarner | $31.73
-3.0% | 12/12/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | $41.00 -> $41.00 | N/A | View details for Guggenheim rating of BorgWarner (NYSE:BWA) on 12/12/2024 |
ANAB AnaptysBio | $15.74
-2.7% | 12/12/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $90.00 -> $36.00 | N/A | View details for Guggenheim rating of AnaptysBio (NASDAQ:ANAB) on 12/12/2024 |
WBD Warner Bros. Discovery | $10.12
+0.7% | 12/12/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $11.00 -> $12.50 | N/A | View details for Guggenheim rating of Warner Bros. Discovery (NASDAQ:WBD) on 12/12/2024 |
ADCT ADC Therapeutics | $1.69
-0.9% | 12/12/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | $10.00 -> $10.00 | N/A | View details for Guggenheim rating of ADC Therapeutics (NYSE:ADCT) on 12/12/2024 |
LOW Lowe's Companies | $258.68
+0.3% | 12/12/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | $300.00 -> $300.00 | N/A | View details for Guggenheim rating of Lowe’s Companies (NYSE:LOW) on 12/12/2024 |
M Macy's | $14.63
+0.2% | 12/12/2024 | Reiterated by | Guggenheim | - | Neutral -> Neutral | | N/A | View details for Guggenheim rating of Macy’s (NYSE:M) on 12/12/2024 |
SPRB Spruce Biosciences | $0.38
+0.4% | 12/12/2024 | Reiterated by | Guggenheim | - | Neutral -> Neutral | | N/A | View details for Guggenheim rating of Spruce Biosciences (NASDAQ:SPRB) on 12/12/2024 |
UNFI United Natural Foods | $27.18
-0.5% | 12/12/2024 | Reiterated by | Guggenheim | Analyst J. Heinbockel | Neutral -> Neutral | | N/A | View details for Guggenheim rating of United Natural Foods (NYSE:UNFI) on 12/12/2024 |
BPMC Blueprint Medicines | $112.65
+0.6% | 12/11/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | | N/A | View details for Guggenheim rating of Blueprint Medicines (NASDAQ:BPMC) on 12/11/2024 |
PEG Public Service Enterprise Group | $87.97
-0.3% | 12/11/2024 | Reiterated by | Guggenheim | Analyst S. Pourreza | Buy -> Buy | | N/A | View details for Guggenheim rating of Public Service Enterprise Group (NYSE:PEG) on 12/11/2024 |
QURE uniQure | $15.19
-0.7% | 12/11/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | | N/A | View details for Guggenheim rating of uniQure (NASDAQ:QURE) on 12/11/2024 |
TRML Tourmaline Bio | $17.82
+1.0% | 12/11/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | | N/A | View details for Guggenheim rating of Tourmaline Bio (NASDAQ:TRML) on 12/11/2024 |
AZO AutoZone | $3,335.47
+1.1% | 12/11/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $3,350.00 -> $3,750.00 | N/A | View details for Guggenheim rating of AutoZone (NYSE:AZO) on 12/11/2024 |
GEV GE Vernova | $428.16
+0.2% | 12/11/2024 | Target Lowered by | Guggenheim | Analyst J. Osha | Buy -> Buy | $400.00 -> $380.00 | N/A | View details for Guggenheim rating of GE Vernova (NYSE:GEV) on 12/11/2024 |
GIII G-III Apparel Group | $31.00
-1.4% | 12/11/2024 | Target Raised by | Guggenheim | Analyst R. Drbul | Buy -> Buy | $36.00 -> $38.00 | N/A | View details for Guggenheim rating of G-III Apparel Group (NASDAQ:GIII) on 12/11/2024 |
PFE Pfizer | $25.98
-0.1% | 12/11/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $35.00 -> $33.00 | N/A | View details for Guggenheim rating of Pfizer (NYSE:PFE) on 12/11/2024 |
VFC VF | $24.86
-1.0% | 12/11/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $25.00 -> $27.00 | N/A | View details for Guggenheim rating of VF (NYSE:VFC) on 12/11/2024 |
SIRI Sirius XM | $21.94
-0.7% | 12/11/2024 | Reiterated by | Guggenheim | Analyst C. Baker | Buy -> Buy | $30.00 -> $30.00 | N/A | View details for Guggenheim rating of Sirius XM (NASDAQ:SIRI) on 12/11/2024 |
QTTB Q32 Bio | $3.41
+0.3% | 12/11/2024 | Downgraded by | Guggenheim | Analyst Y. Suneja | Buy -> Neutral | | N/A | View details for Guggenheim rating of Q32 Bio (NASDAQ:QTTB) on 12/11/2024 |
TEM Tempus AI | $48.60
-3.7% | 12/9/2024 | Initiated by | Guggenheim | Analyst S. Nambi | Buy | $74.00 | N/A | View details for Guggenheim rating of Tempus AI (NASDAQ:TEM) on 12/9/2024 |
TARA Protara Therapeutics | $4.63
-2.8% | 12/6/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | $20.00 -> $20.00 | N/A | View details for Guggenheim rating of Protara Therapeutics (NASDAQ:TARA) on 12/6/2024 |
CROX Crocs | $100.72
-1.9% | 12/6/2024 | Reiterated by | Guggenheim | Analyst R. Drbul | Buy -> Buy | $155.00 -> $155.00 | N/A | View details for Guggenheim rating of Crocs (NASDAQ:CROX) on 12/6/2024 |
DLTR Dollar Tree | $71.28
-1.0% | 12/6/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $120.00 -> $100.00 | N/A | View details for Guggenheim rating of Dollar Tree (NASDAQ:DLTR) on 12/6/2024 |
PVH PVH | $94.22
-2.1% | 12/6/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $105.00 -> $125.00 | N/A | View details for Guggenheim rating of PVH (NYSE:PVH) on 12/6/2024 |
RBRK Rubrik | $71.08
-0.4% | 12/6/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $52.00 -> $72.00 | N/A | View details for Guggenheim rating of Rubrik (NYSE:RBRK) on 12/6/2024 |
LULU Lululemon Athletica | $384.00
+0.3% | 12/6/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $350.00 -> $415.00 | N/A | View details for Guggenheim rating of Lululemon Athletica (NASDAQ:LULU) on 12/6/2024 |
FLNC Fluence Energy | $13.31
-0.2% | 12/6/2024 | Reiterated by | Guggenheim | Analyst J. Osha | Buy -> Buy | $26.00 -> $26.00 | N/A | View details for Guggenheim rating of Fluence Energy (NASDAQ:FLNC) on 12/6/2024 |
TSLA Tesla | $415.07
0.0% | 12/5/2024 | Target Raised by | Guggenheim | - | Sell -> Sell | $156.00 -> $175.00 | N/A | View details for Guggenheim rating of Tesla (NASDAQ:TSLA) on 12/5/2024 |
S SentinelOne | $23.16
-0.3% | 12/5/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | $31.00 -> $31.00 | N/A | View details for Guggenheim rating of SentinelOne (NYSE:S) on 12/5/2024 |
APTV Aptiv | $63.79
+1.7% | 12/5/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | $73.00 -> $73.00 | N/A | View details for Guggenheim rating of Aptiv (NYSE:APTV) on 12/5/2024 |
ORCL Oracle | $184.34
+0.1% | 12/5/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $200.00 -> $220.00 | N/A | View details for Guggenheim rating of Oracle (NYSE:ORCL) on 12/5/2024 |
TJX TJX Companies | $122.68
+0.1% | 12/5/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $135.00 -> $140.00 | N/A | View details for Guggenheim rating of TJX Companies (NYSE:TJX) on 12/5/2024 |
FIVE Five Below | $93.09
+0.3% | 12/5/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $125.00 -> $140.00 | N/A | View details for Guggenheim rating of Five Below (NASDAQ:FIVE) on 12/5/2024 |
FL Foot Locker | $20.71
+0.7% | 12/5/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $34.00 -> $28.00 | N/A | View details for Guggenheim rating of Foot Locker (NYSE:FL) on 12/5/2024 |
GEV GE Vernova | $428.16
+0.2% | 12/5/2024 | Target Raised by | Guggenheim | Analyst J. Osha | Buy -> Buy | $300.00 -> $400.00 | N/A | View details for Guggenheim rating of GE Vernova (NYSE:GEV) on 12/5/2024 |
RH RH | $440.38
-3.1% | 12/4/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | $425.00 -> $425.00 | N/A | View details for Guggenheim rating of RH (NYSE:RH) on 12/4/2024 |
URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad) Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days.
It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year.
This is where fortunes are made – often LITERALLY overnight. >> Register for the Workshop Now |
CRM Salesforce | $331.28
-0.4% | 12/4/2024 | Reiterated by | Guggenheim | - | Neutral -> Neutral | | N/A | View details for Guggenheim rating of Salesforce (NYSE:CRM) on 12/4/2024 |
OKTA Okta | $87.43
-1.3% | 12/4/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | $130.00 -> $130.00 | N/A | View details for Guggenheim rating of Okta (NASDAQ:OKTA) on 12/4/2024 |
WMG Warner Music Group | $30.07
+0.2% | 12/4/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | $44.00 -> $44.00 | N/A | View details for Guggenheim rating of Warner Music Group (NASDAQ:WMG) on 12/4/2024 |
BASE Couchbase | $16.93
-0.4% | 12/4/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | $30.00 -> $30.00 | N/A | View details for Guggenheim rating of Couchbase (NASDAQ:BASE) on 12/4/2024 |
KROS Keros Therapeutics | $11.36
-0.3% | 12/4/2024 | Reiterated by | Guggenheim | Analyst V. Divan | Buy -> Buy | $96.00 -> $102.00 | N/A | View details for Guggenheim rating of Keros Therapeutics (NASDAQ:KROS) on 12/4/2024 |
LYV Live Nation Entertainment | $137.76
-0.6% | 12/4/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $146.00 -> $155.00 | N/A | View details for Guggenheim rating of Live Nation Entertainment (NYSE:LYV) on 12/4/2024 |
AZO AutoZone | $3,335.47
+1.1% | 12/4/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | | N/A | View details for Guggenheim rating of AutoZone (NYSE:AZO) on 12/4/2024 |
SNAP Snap | $10.48
+0.1% | 12/3/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | $12.11 -> $12.11 | N/A | View details for Guggenheim rating of Snap (NYSE:SNAP) on 12/3/2024 |
RVMD Revolution Medicines | $40.62
-0.7% | 12/3/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $82.00 -> $87.00 | N/A | View details for Guggenheim rating of Revolution Medicines (NASDAQ:RVMD) on 12/3/2024 |
ABSI Absci | $3.97
-1.6% | 12/3/2024 | Reiterated by | Guggenheim | Analyst V. Divan | Buy -> Buy | $10.00 -> $10.00 | N/A | View details for Guggenheim rating of Absci (NASDAQ:ABSI) on 12/3/2024 |
APGE Apogee Therapeutics | $37.89
-4.0% | 12/3/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | $95.00 -> $110.00 | N/A | View details for Guggenheim rating of Apogee Therapeutics (NASDAQ:APGE) on 12/3/2024 |
BNTC Benitec Biopharma | $10.85
+0.7% | 12/3/2024 | Reiterated by | Guggenheim | Analyst D. Chattopadhyay | Buy -> Buy | $17.00 -> $17.00 | N/A | View details for Guggenheim rating of Benitec Biopharma (NASDAQ:BNTC) on 12/3/2024 |
PRME Prime Medicine | $3.12
-1.8% | 12/3/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | $18.00 -> $18.00 | N/A | View details for Guggenheim rating of Prime Medicine (NYSE:PRME) on 12/3/2024 |
ZS Zscaler | $191.95
-0.5% | 12/3/2024 | Reiterated by | Guggenheim | - | Neutral | | N/A | View details for Guggenheim rating of Zscaler (NASDAQ:ZS) on 12/3/2024 |
MRUS Merus | $40.70
+2.4% | 12/3/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | $111.00 -> $109.00 | N/A | View details for Guggenheim rating of Merus (NASDAQ:MRUS) on 12/3/2024 |
KSS Kohl's | $13.46
+0.7% | 12/2/2024 | Downgraded by | Guggenheim | Analyst R. Drbul | Buy -> Neutral | | N/A | View details for Guggenheim rating of Kohl’s (NYSE:KSS) on 12/2/2024 |
BBY Best Buy | $84.37
+0.5% | 11/29/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $110.00 -> $105.00 | N/A | View details for Guggenheim rating of Best Buy (NYSE:BBY) on 11/29/2024 |
APGE Apogee Therapeutics | $37.89
-4.0% | 11/27/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $95.00 -> $110.00 | N/A | View details for Guggenheim rating of Apogee Therapeutics (NASDAQ:APGE) on 11/27/2024 |
KSS Kohl's | $13.46
+0.7% | 11/27/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $26.00 -> $25.00 | N/A | View details for Guggenheim rating of Kohl’s (NYSE:KSS) on 11/27/2024 |
NJR New Jersey Resources | $46.66
+0.1% | 11/27/2024 | Target Raised by | Guggenheim | - | Neutral -> Neutral | $46.00 -> $49.00 | N/A | View details for Guggenheim rating of New Jersey Resources (NYSE:NJR) on 11/27/2024 |
CPRI Capri | $24.49
-0.3% | 11/26/2024 | Upgraded by | Guggenheim | Analyst R. Drbul | Neutral -> Buy | $30.00 | N/A | View details for Guggenheim rating of Capri (NYSE:CPRI) on 11/26/2024 |
KR Kroger | $58.60
-0.7% | 11/25/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $61.00 -> $63.00 | N/A | View details for Guggenheim rating of Kroger (NYSE:KR) on 11/25/2024 |
NXT Nextracker | $40.12
-2.6% | 11/22/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | $55.00 -> $55.00 | N/A | View details for Guggenheim rating of Nextracker (NASDAQ:NXT) on 11/22/2024 |
ROST Ross Stores | $148.78
-0.7% | 11/22/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | $180.00 -> $180.00 | N/A | View details for Guggenheim rating of Ross Stores (NASDAQ:ROST) on 11/22/2024 |
WMG Warner Music Group | $30.07
+0.2% | 11/22/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | $44.00 -> $44.00 | N/A | View details for Guggenheim rating of Warner Music Group (NASDAQ:WMG) on 11/22/2024 |
CPK Chesapeake Utilities | $119.76
-0.9% | 11/22/2024 | Target Raised by | Guggenheim | - | Neutral -> Neutral | $118.00 -> $129.00 | N/A | View details for Guggenheim rating of Chesapeake Utilities (NYSE:CPK) on 11/22/2024 |
ESTC Elastic | $104.04
+2.8% | 11/22/2024 | Target Raised by | Guggenheim | Analyst H. Ma | Buy -> Buy | $100.00 -> $120.00 | N/A | View details for Guggenheim rating of Elastic (NYSE:ESTC) on 11/22/2024 |
GAP GAP | $24.57
-0.3% | 11/22/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | $35.00 -> $35.00 | N/A | View details for Guggenheim rating of GAP (NYSE:GAP) on 11/22/2024 |
SHLS Shoals Technologies Group | $4.38
+2.0% | 11/21/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $8.00 -> $7.00 | N/A | View details for Guggenheim rating of Shoals Technologies Group (NASDAQ:SHLS) on 11/21/2024 |
TGT Target | $135.92
+0.1% | 11/21/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $180.00 -> $145.00 | N/A | View details for Guggenheim rating of Target (NYSE:TGT) on 11/21/2024 |
AN AutoNation | $182.66
-1.4% | 11/21/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $190.00 -> $189.00 | N/A | View details for Guggenheim rating of AutoNation (NYSE:AN) on 11/21/2024 |
APTV Aptiv | $63.79
+1.7% | 11/21/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $87.00 -> $73.00 | N/A | View details for Guggenheim rating of Aptiv (NYSE:APTV) on 11/21/2024 |
GNTX Gentex | $27.47
-1.9% | 11/21/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $35.00 -> $34.00 | N/A | View details for Guggenheim rating of Gentex (NASDAQ:GNTX) on 11/21/2024 |
GPI Group 1 Automotive | $440.75
-1.5% | 11/21/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $420.00 -> $442.00 | N/A | View details for Guggenheim rating of Group 1 Automotive (NYSE:GPI) on 11/21/2024 |
LAD Lithia Motors | $344.13
-0.4% | 11/21/2024 | Target Raised by | Guggenheim | Analyst R. Jewsikow | Buy -> Buy | $380.00 -> $418.00 | N/A | View details for Guggenheim rating of Lithia Motors (NYSE:LAD) on 11/21/2024 |
WMT Walmart | $92.71
-0.6% | 11/20/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $90.00 -> $100.00 | N/A | View details for Guggenheim rating of Walmart (NYSE:WMT) on 11/20/2024 |
JACK Jack in the Box | $37.92
-2.5% | 11/20/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $95.00 -> $60.00 | N/A | View details for Guggenheim rating of Jack in the Box (NASDAQ:JACK) on 11/20/2024 |
SEDG SolarEdge Technologies | $12.65
-3.1% | 11/20/2024 | Upgraded by | Guggenheim | Analyst J. Osha | Sell -> Neutral | | N/A | View details for Guggenheim rating of SolarEdge Technologies (NASDAQ:SEDG) on 11/20/2024 |
RBRK Rubrik | $71.08
-0.4% | 11/19/2024 | Target Raised by | Guggenheim | Analyst J. Difucci | Buy -> Buy | $48.00 -> $52.00 | N/A | View details for Guggenheim rating of Rubrik (NYSE:RBRK) on 11/19/2024 |
SBGI Sinclair | $14.52
+0.1% | 11/19/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $18.00 -> $19.00 | N/A | View details for Guggenheim rating of Sinclair (NASDAQ:SBGI) on 11/19/2024 |
FUN Cedar Fair | $44.96
-1.2% | 11/19/2024 | Target Raised by | Guggenheim | Analyst C. Baker | Buy -> Buy | $52.00 -> $55.00 | N/A | View details for Guggenheim rating of Cedar Fair (NYSE:FUN) on 11/19/2024 |
IHRT iHeartMedia | $2.35
0.0% | 11/19/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $3.00 -> $5.00 | N/A | View details for Guggenheim rating of iHeartMedia (NASDAQ:IHRT) on 11/19/2024 |
ADAP Adaptimmune Therapeutics | $0.56
-2.0% | 11/15/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $4.00 -> $3.00 | N/A | View details for Guggenheim rating of Adaptimmune Therapeutics (NASDAQ:ADAP) on 11/15/2024 |
CNTA Centessa Pharmaceuticals | $16.60
+0.9% | 11/15/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $24.00 -> $28.00 | N/A | View details for Guggenheim rating of Centessa Pharmaceuticals (NASDAQ:CNTA) on 11/15/2024 |
DIS Walt Disney | $108.97
+0.1% | 11/15/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $110.00 -> $130.00 | N/A | View details for Guggenheim rating of Walt Disney (NYSE:DIS) on 11/15/2024 |
TPR Tapestry | $72.75
-0.8% | 11/15/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $60.00 -> $70.00 | N/A | View details for Guggenheim rating of Tapestry (NYSE:TPR) on 11/15/2024 |
ZNTL Zentalis Pharmaceuticals | $2.21
-2.4% | 11/15/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $12.00 -> $8.00 | N/A | View details for Guggenheim rating of Zentalis Pharmaceuticals (NASDAQ:ZNTL) on 11/15/2024 |
GTN Gray Television | $3.44
+0.1% | 11/12/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $10.00 -> $8.00 | N/A | View details for Guggenheim rating of Gray Television (NYSE:GTN) on 11/12/2024 |
LYV Live Nation Entertainment | $137.76
-0.6% | 11/12/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $130.00 -> $146.00 | N/A | View details for Guggenheim rating of Live Nation Entertainment (NYSE:LYV) on 11/12/2024 |
SPHR Sphere Entertainment | $41.03
-1.1% | 11/12/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $49.00 -> $48.00 | N/A | View details for Guggenheim rating of Sphere Entertainment (NYSE:SPHR) on 11/12/2024 |
URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad) Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days.
It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year.
This is where fortunes are made – often LITERALLY overnight. >> Register for the Workshop Now |
NWSA News | $27.78
-0.1% | 11/12/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $36.00 -> $40.00 | N/A | View details for Guggenheim rating of News (NASDAQ:NWSA) on 11/12/2024 |
PRKS United Parks & Resorts | $51.67
-0.6% | 11/12/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $72.00 -> $70.00 | N/A | View details for Guggenheim rating of United Parks & Resorts (NYSE:PRKS) on 11/12/2024 |
SMAR Smartsheet | $56.48
+0.0% | 11/11/2024 | Downgraded by | Guggenheim | Analyst J. Difucci | Buy -> Neutral | | N/A | View details for Guggenheim rating of Smartsheet (NYSE:SMAR) on 11/11/2024 |
CDTX Cidara Therapeutics | $21.34
-3.8% | 11/8/2024 | Initiated by | Guggenheim | Analyst S. Fernandez | Buy | $33.00 | N/A | View details for Guggenheim rating of Cidara Therapeutics (NASDAQ:CDTX) on 11/8/2024 |
SIRI Sirius XM | $21.94
-0.7% | 11/6/2024 | Downgraded by | Guggenheim | Analyst C. Baker | Strong-Buy -> Hold | | N/A | View details for Guggenheim rating of Sirius XM (NASDAQ:SIRI) on 11/6/2024 |
FOLD Amicus Therapeutics | $9.51
| 11/7/2024 | Target Raised by | Guggenheim | Analyst D. Chattopadhyay | Buy -> Buy | $13.00 -> $15.00 | N/A | View details for Guggenheim rating of Amicus Therapeutics (NASDAQ:FOLD) on 11/7/2024 |
PFGC Performance Food Group | $88.90
-0.3% | 11/7/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $90.00 -> $95.00 | N/A | View details for Guggenheim rating of Performance Food Group (NYSE:PFGC) on 11/7/2024 |
SRPT Sarepta Therapeutics | $116.10
-0.6% | 11/7/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $148.00 -> $150.00 | N/A | View details for Guggenheim rating of Sarepta Therapeutics (NASDAQ:SRPT) on 11/7/2024 |
TNGX Tango Therapeutics | $3.07
-0.5% | 11/7/2024 | Target Lowered by | Guggenheim | Analyst M. Schmidt | Buy -> Buy | $18.00 -> $8.00 | N/A | View details for Guggenheim rating of Tango Therapeutics (NASDAQ:TNGX) on 11/7/2024 |
RUN Sunrun | $8.30
-1.9% | 11/7/2024 | Downgraded by | Guggenheim | Analyst J. Osha | Buy -> Neutral | | N/A | View details for Guggenheim rating of Sunrun (NASDAQ:RUN) on 11/7/2024 |
NOVA Sunnova Energy International | $2.81
-3.6% | 11/7/2024 | Downgraded by | Guggenheim | Analyst J. Osha | Buy -> Neutral | | N/A | View details for Guggenheim rating of Sunnova Energy International (NYSE:NOVA) on 11/7/2024 |
ARRY Array Technologies | $6.34
-0.9% | 11/7/2024 | Downgraded by | Guggenheim | Analyst J. Osha | Buy -> Neutral | | N/A | View details for Guggenheim rating of Array Technologies (NASDAQ:ARRY) on 11/7/2024 |
JNJ Johnson & Johnson | $146.58
+0.9% | 11/6/2024 | Target Raised by | Guggenheim | - | Neutral -> Neutral | $156.00 -> $162.00 | N/A | View details for Guggenheim rating of Johnson & Johnson (NYSE:JNJ) on 11/6/2024 |
MRK Merck & Co., Inc. | $95.88
+0.2% | 11/6/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $137.00 -> $130.00 | N/A | View details for Guggenheim rating of Merck & Co., Inc. (NYSE:MRK) on 11/6/2024 |
RIVN Rivian Automotive | $12.47
-1.7% | 11/6/2024 | Target Lowered by | Guggenheim | Analyst R. Jewsikow | Buy -> Buy | $21.00 -> $18.00 | N/A | View details for Guggenheim rating of Rivian Automotive (NASDAQ:RIVN) on 11/6/2024 |
ABBV AbbVie | $169.11
-0.1% | 11/6/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $212.00 -> $221.00 | N/A | View details for Guggenheim rating of AbbVie (NYSE:ABBV) on 11/6/2024 |
DAVA Endava | $31.29
-0.9% | 11/6/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $45.00 -> $40.00 | N/A | View details for Guggenheim rating of Endava (NYSE:DAVA) on 11/6/2024 |
ITRI Itron | $106.25
+0.1% | 11/6/2024 | Target Raised by | Guggenheim | Analyst J. Osha | Buy -> Buy | $128.00 -> $135.00 | N/A | View details for Guggenheim rating of Itron (NASDAQ:ITRI) on 11/6/2024 |
FOXA FOX | $48.19
+0.6% | 11/5/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $45.00 -> $50.00 | Medium | View details for Guggenheim rating of FOX (NASDAQ:FOXA) on 11/5/2024 |
KTB Kontoor Brands | $87.97
-1.0% | 11/1/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $80.00 -> $100.00 | Medium | View details for Guggenheim rating of Kontoor Brands (NYSE:KTB) on 11/1/2024 |
ETR Entergy | $82.63
-1.2% | 11/1/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $72.50 -> $82.50 | Low | View details for Guggenheim rating of Entergy (NYSE:ETR) on 11/1/2024 |
KYMR Kymera Therapeutics | $43.80
-0.7% | 11/1/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $45.00 -> $52.00 | Medium | View details for Guggenheim rating of Kymera Therapeutics (NASDAQ:KYMR) on 11/1/2024 |
ARGX argenx | $642.22
-0.8% | 11/1/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $585.00 -> $665.00 | High | View details for Guggenheim rating of argenx (NASDAQ:ARGX) on 11/1/2024 |
GSK GSK | $33.82
+1.2% | 10/31/2024 | Downgraded by | Guggenheim | Analyst S. Fernandez | Buy -> Neutral | | Medium | View details for Guggenheim rating of GSK (NYSE:GSK) on 10/31/2024 |
CROX Crocs | $100.72
-1.9% | 10/30/2024 | Target Lowered by | Guggenheim | Analyst R. Drbul | Buy -> Buy | $182.00 -> $155.00 | Low | View details for Guggenheim rating of Crocs (NASDAQ:CROX) on 10/30/2024 |
EXEL Exelixis | $32.84
-0.1% | 10/30/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $32.00 -> $33.00 | Medium | View details for Guggenheim rating of Exelixis (NASDAQ:EXEL) on 10/30/2024 |
FSLR First Solar | $168.52
-2.0% | 10/30/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $368.00 -> $335.00 | Medium | View details for Guggenheim rating of First Solar (NASDAQ:FSLR) on 10/30/2024 |
NFLX Netflix | $973.98
+2.1% | 10/29/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $810.00 -> $825.00 | N/A | View details for Guggenheim rating of Netflix (NASDAQ:NFLX) on 10/29/2024 |
FUN Cedar Fair | $44.96
-1.2% | 10/29/2024 | Initiated by | Guggenheim | Analyst C. Baker | Buy | $52.00 | Medium | View details for Guggenheim rating of Cedar Fair (NYSE:FUN) on 10/29/2024 |
GNLX Genelux | $3.26
+3.3% | 10/29/2024 | Initiated by | Guggenheim | Analyst K. Goodwin | Buy | $8.00 | Low | View details for Guggenheim rating of Genelux (NASDAQ:GNLX) on 10/29/2024 |
RL Ralph Lauren | $249.81
-0.2% | 10/28/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $200.00 -> $225.00 | Low | View details for Guggenheim rating of Ralph Lauren (NYSE:RL) on 10/28/2024 |
PVH PVH | $94.22
-2.1% | 10/28/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $120.00 -> $105.00 | Medium | View details for Guggenheim rating of PVH (NYSE:PVH) on 10/28/2024 |
WMT Walmart | $92.71
-0.6% | 10/28/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $81.00 -> $90.00 | Low | View details for Guggenheim rating of Walmart (NYSE:WMT) on 10/28/2024 |
VERA Vera Therapeutics | $33.62
-0.2% | 10/28/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $56.00 -> $64.00 | High | View details for Guggenheim rating of Vera Therapeutics (NASDAQ:VERA) on 10/28/2024 |
RVMD Revolution Medicines | $40.62
-0.7% | 10/28/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $72.00 -> $82.00 | Medium | View details for Guggenheim rating of Revolution Medicines (NASDAQ:RVMD) on 10/28/2024 |
NEP NextEra Energy Partners | $15.74
-1.2% | 10/28/2024 | Downgraded by | Guggenheim | Analyst S. Pourreza | Buy -> Neutral | $37.00 -> $22.00 | Medium | View details for Guggenheim rating of NextEra Energy Partners (NYSE:NEP) on 10/28/2024 |
SYRE Spyre Therapeutics | $21.35
-4.2% | 10/25/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $50.00 -> $65.00 | Medium | View details for Guggenheim rating of Spyre Therapeutics (NASDAQ:SYRE) on 10/25/2024 |
LAD Lithia Motors | $344.13
-0.4% | 10/24/2024 | Target Raised by | Guggenheim | Analyst R. Jewsikow | Buy -> Buy | $350.00 -> $380.00 | Low | View details for Guggenheim rating of Lithia Motors (NYSE:LAD) on 10/24/2024 |
NEE NextEra Energy | $68.54
+0.1% | 10/24/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $90.00 -> $92.00 | Low | View details for Guggenheim rating of NextEra Energy (NYSE:NEE) on 10/24/2024 |
TSLA Tesla | $415.07
0.0% | 10/24/2024 | Target Raised by | Guggenheim | - | Sell -> Sell | $153.00 -> $156.00 | Medium | View details for Guggenheim rating of Tesla (NASDAQ:TSLA) on 10/24/2024 |
MCD McDonald's | $281.32
0.0% | 10/23/2024 | Downgraded by | Guggenheim | Analyst G. Francfort | Buy -> Neutral | $290.00 -> $285.00 | High | View details for Guggenheim rating of McDonald’s (NYSE:MCD) on 10/23/2024 |
ENPH Enphase Energy | $59.72
-2.1% | 10/23/2024 | Downgraded by | Guggenheim | Analyst J. Osha | Neutral -> Sell | $73.00 | Low | View details for Guggenheim rating of Enphase Energy (NASDAQ:ENPH) on 10/23/2024 |
ANAB AnaptysBio | $15.74
-2.7% | 10/21/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $75.00 -> $90.00 | Low | View details for Guggenheim rating of AnaptysBio (NASDAQ:ANAB) on 10/21/2024 |
RYTM Rhythm Pharmaceuticals | $56.92
-0.5% | 10/21/2024 | Initiated by | Guggenheim | Analyst S. Fernandez | Buy | $70.00 | High | View details for Guggenheim rating of Rhythm Pharmaceuticals (NASDAQ:RYTM) on 10/21/2024 |
INFA Informatica | $24.84
-0.1% | 10/18/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | | Low | View details for Guggenheim rating of Informatica (NYSE:INFA) on 10/18/2024 |
PSTG Pure Storage | $72.16
-0.2% | 10/17/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $72.00 -> $93.00 | High | View details for Guggenheim rating of Pure Storage (NYSE:PSTG) on 10/17/2024 |
GRAL Grail | $23.01
+1.6% | 10/17/2024 | Initiated by | Guggenheim | Analyst S. Nambi | Neutral | | Medium | View details for Guggenheim rating of Grail (NASDAQ:GRAL) on 10/17/2024 |
SEDG SolarEdge Technologies | $12.65
-3.1% | 10/17/2024 | Downgraded by | Guggenheim | Analyst J. Osha | Neutral -> Sell | $10.00 | Low | View details for Guggenheim rating of SolarEdge Technologies (NASDAQ:SEDG) on 10/17/2024 |
ENPH Enphase Energy | $59.72
-2.1% | 10/17/2024 | Upgraded by | Guggenheim | Analyst J. Osha | Sell -> Neutral | | Medium | View details for Guggenheim rating of Enphase Energy (NASDAQ:ENPH) on 10/17/2024 |
CVLT Commvault Systems | $161.58
-0.7% | 10/15/2024 | Downgraded by | Guggenheim | Analyst H. Ma | Buy -> Neutral | | High | View details for Guggenheim rating of Commvault Systems (NASDAQ:CVLT) on 10/15/2024 |
URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad) Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days.
It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year.
This is where fortunes are made – often LITERALLY overnight. >> Register for the Workshop Now |
TENX Tenax Therapeutics | $6.55
+0.8% | 10/14/2024 | Initiated by | Guggenheim | Analyst S. Fernandez | Buy | $16.00 | High | View details for Guggenheim rating of Tenax Therapeutics (NASDAQ:TENX) on 10/14/2024 |
NFLX Netflix | $973.98
+2.1% | 10/11/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $735.00 -> $810.00 | Medium | View details for Guggenheim rating of Netflix (NASDAQ:NFLX) on 10/11/2024 |
VCYT Veracyte | $42.72
-2.0% | 10/10/2024 | Initiated by | Guggenheim | Analyst S. Nambi | Buy | $40.00 | High | View details for Guggenheim rating of Veracyte (NASDAQ:VCYT) on 10/10/2024 |
TVTX Travere Therapeutics | $19.20
-1.3% | 10/9/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $23.00 -> $41.00 | High | View details for Guggenheim rating of Travere Therapeutics (NASDAQ:TVTX) on 10/9/2024 |
IONS Ionis Pharmaceuticals | $33.13
+1.9% | 10/9/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $70.00 -> $65.00 | Low | View details for Guggenheim rating of Ionis Pharmaceuticals (NASDAQ:IONS) on 10/9/2024 |
GIII G-III Apparel Group | $31.00
-1.4% | 10/9/2024 | Initiated by | Guggenheim | Analyst R. Drbul | Buy | $36.00 | High | View details for Guggenheim rating of G-III Apparel Group (NASDAQ:GIII) on 10/9/2024 |
DECK Deckers Outdoor | $211.13
-1.8% | 10/9/2024 | Initiated by | Guggenheim | Analyst R. Drbul | Neutral | | Low | View details for Guggenheim rating of Deckers Outdoor (NYSE:DECK) on 10/9/2024 |
CROX Crocs | $100.72
-1.9% | 10/9/2024 | Initiated by | Guggenheim | Analyst R. Drbul | Buy | $182.00 | Low | View details for Guggenheim rating of Crocs (NASDAQ:CROX) on 10/9/2024 |
VST Vistra | $190.24
+1.8% | 10/8/2024 | Target Raised by | Guggenheim | Analyst S. Pourreza | Buy -> Buy | $133.00 -> $177.00 | Low | View details for Guggenheim rating of Vistra (NYSE:VST) on 10/8/2024 |
TLN Talen Energy | $251.78
+0.7% | 10/8/2024 | Target Raised by | Guggenheim | Analyst S. Pourreza | Buy -> Buy | $219.00 -> $246.00 | N/A | View details for Guggenheim rating of Talen Energy (NASDAQ:TLN) on 10/8/2024 |
NRG NRG Energy | $110.97
+0.6% | 10/8/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $77.00 -> $118.00 | Medium | View details for Guggenheim rating of NRG Energy (NYSE:NRG) on 10/8/2024 |
MBX MBX Biosciences | $10.97
+7.2% | 10/8/2024 | Initiated by | Guggenheim | Analyst S. Fernandez | Buy | $44.00 | High | View details for Guggenheim rating of MBX Biosciences (NYSE:MBX) on 10/8/2024 |
META Meta Platforms | $625.20
+0.3% | 10/7/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $600.00 -> $665.00 | N/A | View details for Guggenheim rating of Meta Platforms (NASDAQ:META) on 10/7/2024 |
SN SharkNinja | $110.10
+0.1% | 10/7/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $100.00 -> $120.00 | Low | View details for Guggenheim rating of SharkNinja (NYSE:SN) on 10/7/2024 |
IMCR Immunocore | $31.11
+3.7% | 10/7/2024 | Downgraded by | Guggenheim | Analyst M. Schmidt | Buy -> Neutral | | High | View details for Guggenheim rating of Immunocore (NASDAQ:IMCR) on 10/7/2024 |
ZVRA Zevra Therapeutics | $8.25
+1.2% | 10/7/2024 | Initiated by | Guggenheim | Analyst E. Hickman | Buy | $20.00 | High | View details for Guggenheim rating of Zevra Therapeutics (NASDAQ:ZVRA) on 10/7/2024 |
NXST Nexstar Media Group | $155.95
+1.5% | 10/4/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $200.00 -> $198.00 | Low | View details for Guggenheim rating of Nexstar Media Group (NASDAQ:NXST) on 10/4/2024 |
HD Home Depot | $410.89
+0.2% | 10/4/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $390.00 -> $450.00 | Low | View details for Guggenheim rating of Home Depot (NYSE:HD) on 10/4/2024 |
ARRY Array Technologies | $6.34
-0.9% | 10/4/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $14.00 -> $12.00 | N/A | View details for Guggenheim rating of Array Technologies (NASDAQ:ARRY) on 10/4/2024 |
ENPH Enphase Energy | $59.72
-2.1% | 10/4/2024 | Target Lowered by | Guggenheim | - | Sell -> Sell | $93.00 -> $90.00 | Medium | View details for Guggenheim rating of Enphase Energy (NASDAQ:ENPH) on 10/4/2024 |
FWRG First Watch Restaurant Group | $18.89
-0.2% | 10/4/2024 | Target Lowered by | Guggenheim | Analyst G. Francfort | Buy -> Buy | $24.00 -> $20.00 | Medium | View details for Guggenheim rating of First Watch Restaurant Group (NASDAQ:FWRG) on 10/4/2024 |
SO Southern | $82.66
+0.2% | 10/2/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $93.00 -> $97.00 | Low | View details for Guggenheim rating of Southern (NYSE:SO) on 10/2/2024 |
NKE NIKE | $72.72
-1.8% | 10/2/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $115.00 -> $110.00 | Low | View details for Guggenheim rating of NIKE (NYSE:NKE) on 10/2/2024 |
ABSI Absci | $3.97
-1.6% | 10/2/2024 | Initiated by | Guggenheim | Analyst V. Divan | Buy | $10.00 | High | View details for Guggenheim rating of Absci (NASDAQ:ABSI) on 10/2/2024 |
BTSG BrightSpring Health Services | $21.38
+0.9% | 10/1/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $15.00 -> $18.00 | Medium | View details for Guggenheim rating of BrightSpring Health Services (NASDAQ:BTSG) on 10/1/2024 |
IGMS IGM Biosciences | $1.72
+0.9% | 10/1/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $25.00 -> $20.00 | Medium | View details for Guggenheim rating of IGM Biosciences (NASDAQ:IGMS) on 10/1/2024 |
MRUS Merus | $40.70
+2.4% | 10/1/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $93.00 -> $111.00 | Low | View details for Guggenheim rating of Merus (NASDAQ:MRUS) on 10/1/2024 |
VEEV Veeva Systems | $218.73
-4.5% | 10/1/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $233.00 -> $249.00 | Low | View details for Guggenheim rating of Veeva Systems (NYSE:VEEV) on 10/1/2024 |
TTEC TTEC | $3.77
-3.7% | 10/1/2024 | Upgraded by | Guggenheim | Analyst J. Lee | Sell -> Neutral | | Medium | View details for Guggenheim rating of TTEC (NASDAQ:TTEC) on 10/1/2024 |
TKO TKO Group | $147.11
+2.9% | 9/30/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $135.00 -> $140.00 | Medium | View details for Guggenheim rating of TKO Group (NYSE:TKO) on 9/30/2024 |
ACET Adicet Bio | $0.93
+0.8% | 9/30/2024 | Initiated by | Guggenheim | Analyst M. Schmidt | Hold -> Buy | $7.00 | High | View details for Guggenheim rating of Adicet Bio (NASDAQ:ACET) on 9/30/2024 |
VSTM Verastem | $5.57
+0.9% | 9/30/2024 | Initiated by | Guggenheim | Analyst M. Schmidt | Buy | $13.00 | High | View details for Guggenheim rating of Verastem (NASDAQ:VSTM) on 9/30/2024 |
ACN Accenture | $359.56
+0.1% | 9/27/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $380.00 -> $395.00 | Medium | View details for Guggenheim rating of Accenture (NYSE:ACN) on 9/27/2024 |
DT Dynatrace | $55.14
+3.6% | 9/27/2024 | Target Raised by | Guggenheim | Analyst J. Difucci | Buy -> Buy | $55.00 -> $64.00 | Low | View details for Guggenheim rating of Dynatrace (NYSE:DT) on 9/27/2024 |
TVTX Travere Therapeutics | $19.20
-1.3% | 9/27/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $25.00 -> $23.00 | High | View details for Guggenheim rating of Travere Therapeutics (NASDAQ:TVTX) on 9/27/2024 |
W Wayfair | $46.91
-1.8% | 9/26/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | $70.00 -> $70.00 | Low | View details for Guggenheim rating of Wayfair (NYSE:W) on 9/26/2024 |
DPZ Domino's Pizza | $441.08
-0.2% | 9/26/2024 | Target Lowered by | Guggenheim | - | Neutral -> Neutral | $485.00 -> $460.00 | Low | View details for Guggenheim rating of Domino’s Pizza (NASDAQ:DPZ) on 9/26/2024 |
ARGX argenx | $642.22
-0.8% | 9/26/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | $585.00 -> $585.00 | High | View details for Guggenheim rating of argenx (NASDAQ:ARGX) on 9/26/2024 |
TXRH Texas Roadhouse | $178.62
-0.8% | 9/25/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $190.00 -> $195.00 | Low | View details for Guggenheim rating of Texas Roadhouse (NASDAQ:TXRH) on 9/25/2024 |
PRGS Progress Software | $55.10
-3.8% | 9/25/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $64.00 -> $70.00 | High | View details for Guggenheim rating of Progress Software (NASDAQ:PRGS) on 9/25/2024 |
PARA Paramount Global | $10.53
+0.2% | 9/25/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $19.00 -> $14.00 | Low | View details for Guggenheim rating of Paramount Global (NASDAQ:PARA) on 9/25/2024 |
AZO AutoZone | $3,335.47
+1.1% | 9/25/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $3,225.00 -> $3,350.00 | Low | View details for Guggenheim rating of AutoZone (NYSE:AZO) on 9/25/2024 |
FOXA FOX | $48.19
+0.6% | 9/24/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $44.00 -> $45.00 | Low | View details for Guggenheim rating of FOX (NASDAQ:FOXA) on 9/24/2024 |
GEV GE Vernova | $428.16
+0.2% | 9/24/2024 | Initiated by | Guggenheim | Analyst J. Osha | Buy | $300.00 | Low | View details for Guggenheim rating of GE Vernova (NYSE:GEV) on 9/24/2024 |
KROS Keros Therapeutics | $11.36
-0.3% | 9/23/2024 | Initiated by | Guggenheim | Analyst V. Divan | Buy | $96.00 | High | View details for Guggenheim rating of Keros Therapeutics (NASDAQ:KROS) on 9/23/2024 |
SPHR Sphere Entertainment | $41.03
-1.1% | 9/19/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $58.00 -> $63.00 | Medium | View details for Guggenheim rating of Sphere Entertainment (NYSE:SPHR) on 9/19/2024 |
SIRI Sirius XM | $21.94
-0.7% | 9/18/2024 | Upgraded by | Guggenheim | Analyst C. Baker | Neutral -> Buy | $30.00 | Medium | View details for Guggenheim rating of Sirius XM (NASDAQ:SIRI) on 9/18/2024 |
NUVL Nuvalent | $81.63
+0.4% | 9/16/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $99.00 -> $105.00 | High | View details for Guggenheim rating of Nuvalent (NASDAQ:NUVL) on 9/16/2024 |
INCY Incyte | $71.79
-2.3% | 9/16/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $86.00 -> $92.00 | Medium | View details for Guggenheim rating of Incyte (NASDAQ:INCY) on 9/16/2024 |
DAVA Endava | $31.29
-0.9% | 9/16/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $55.00 -> $45.00 | Medium | View details for Guggenheim rating of Endava (NYSE:DAVA) on 9/16/2024 |
TSLA Tesla | $415.07
0.0% | 9/13/2024 | Target Raised by | Guggenheim | - | Sell -> Sell | $134.00 -> $153.00 | Low | View details for Guggenheim rating of Tesla (NASDAQ:TSLA) on 9/13/2024 |
ORCL Oracle | $184.34
+0.1% | 9/13/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $185.00 -> $200.00 | Low | View details for Guggenheim rating of Oracle (NYSE:ORCL) on 9/13/2024 |
BNTC Benitec Biopharma | $10.85
+0.7% | 9/12/2024 | Initiated by | Guggenheim | Analyst D. Chattopadhyay | Buy | $17.00 | High | View details for Guggenheim rating of Benitec Biopharma (NASDAQ:BNTC) on 9/12/2024 |
CNTA Centessa Pharmaceuticals | $16.60
+0.9% | 9/11/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $20.00 -> $24.00 | High | View details for Guggenheim rating of Centessa Pharmaceuticals (NASDAQ:CNTA) on 9/11/2024 |
ESTC Elastic | $104.04
+2.8% | 9/11/2024 | Initiated by | Guggenheim | Analyst H. Ma | Buy | $100.00 | Medium | View details for Guggenheim rating of Elastic (NYSE:ESTC) on 9/11/2024 |
PROK ProKidney | $1.69
-5.9% | 9/10/2024 | Initiated by | Guggenheim | Analyst V. Divan | Buy | $6.00 | Medium | View details for Guggenheim rating of ProKidney (NASDAQ:PROK) on 9/10/2024 |
QSR Restaurant Brands International | $60.18
-0.6% | 9/9/2024 | Target Raised by | Guggenheim | - | Neutral -> Neutral | $73.00 -> $74.00 | Low | View details for Guggenheim rating of Restaurant Brands International (NYSE:QSR) on 9/9/2024 |
TVTX Travere Therapeutics | $19.20
-1.3% | 9/9/2024 | Upgraded by | Guggenheim | - | Neutral -> Buy | $25.00 | High | View details for Guggenheim rating of Travere Therapeutics (NASDAQ:TVTX) on 9/9/2024 |
DLTR Dollar Tree | $71.28
-1.0% | 9/6/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $150.00 -> $120.00 | Low | View details for Guggenheim rating of Dollar Tree (NASDAQ:DLTR) on 9/6/2024 |
SMAR Smartsheet | $56.48
+0.0% | 9/6/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $60.00 -> $62.00 | Low | View details for Guggenheim rating of Smartsheet (NYSE:SMAR) on 9/6/2024 |
